Interpace Biosciences, Inc. financial statements
Interpace Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 38.73M | 10-K |
| Net income | USD 24.57M | 10-K |
| Cash and equivalents | USD 2.5M | 10-Q |
Interpace Biosciences, Inc. financials on 6ix · Interpace Biosciences, Inc. on 6ix